menu
    • menu
    [{"orgOrder":0,"company":"Catalyst Clinical Research","sponsor":"Moleculin Biotech","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"U.S.A","productType":"Antibiotic","year":"2021","type":"Agreement","leadProduct":"Annamycin","moa":"Topoisomerase II","graph1":"Oncology","graph2":"Preclinical","graph3":"Catalyst Clinical Research","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Intravenous Infusion","sponsorNew":"Catalyst Clinical Research \/ Moleculin Biotech","highestDevelopmentStatusID":"4","companyTruncated":"Catalyst Clinical Research \/ Moleculin Biotech"}]

    Find Clinical Drug Pipeline Developments & Deals by Catalyst Clinical Research

    Menu

    Catalyst Clinical Research

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Catalyst Clinical Research

                            U.S.A arrow
                            IMCAS Asia
                            Not Confirmed

                            Catalyst Clinical Research

                            U.S.A arrow
                            IMCAS Asia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Annamycin

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Moleculin Biotech

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            DEALS_DEV arrow-down

                            Moleculin Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial

                            Details : Catalyst Clinical Research will manage Moleculin's US clinical trial to study the ability of Annamycin to treat soft tissue sarcoma (STS) that has metastasized to the lungs.

                            Product Name : L-ANN

                            Product Type : Antibiotic

                            Upfront Cash : Undisclosed

                            January 02, 2021

                            Lead Product(s) : Annamycin

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Moleculin Biotech

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth